The Mitsuda reaction, a delayed granulomatous skin reaction elicited by the intradermal injection of heat-killed Mycobacterium leprae, is an in vivo test reflecting the ability to generate an immune granuloma after sensitization by diverse mycobacterial infections. Accumulating evidence for the genetic control of the Mitsuda reaction has been reported. We performed a genomewide linkage scan for the quantitative Mitsuda reaction in 19 large families from Vietnam with a history of leprosy (114 offspring). Suggestive linkage was found at chromosomal regions 2q35 ( at the Ϫ4 P p 9 ϫ 10 SLC11A1 locus) and 17q21-25 ( ). Interestingly, Ϫ4
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P p 8 ϫ 10 these 2 regions have been previously linked to mycobacterial infection and other granulomatous diseases.
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which mainly affects skin and peripheral nerves and may lead to pronounced deformities and disabilities. Ap-proximately 300,000 newly diagnosed cases of leprosy were reported worldwide in 2005. Patients with leprosy present a broad spectrum of clinical symptoms, ranging from the tuberculoid form (well-delineated skin and neural lesions without any detectable bacilli and resulting from an efficient specific cellular immune response) to the lepromatous form (disseminated disease with a high bacillary index in the lesions due to an absence of specific cellular immune responses) and including several intermediary forms that are called "borderline leprosy." Only a small fraction of individuals who have long-term, close contact with leprosy patients will develop leprosy themselves, and there is now strong evidence that susceptibility to leprosy is genetically controlled [1, 2] .
The Mitsuda reaction is a granulomatous skin reaction, measured 21-30 days after the intradermal injection of 0.1 mL of lepromin (i.e., heat-killed M. leprae). The results of the Mitsuda test are classically interpreted as a binary outcome, i.e., either negative (!3 mm) or positive (у3 mm). A positive Mitsuda reaction corresponds to the formation of a nodular granuloma composed of epithelioid cells with giant multinucleated cells and associated with a lymphocytic infiltrate, thus involving both antigen-presenting cells (macrophages and dendritic cells) and T lymphocytes [3] . Although not sufficient to prevent the clinical onset of leprosy, the formation of a well-defined granuloma is critical for the containment of the mycobacterial infection. Consequently, patients with a negative Mitsuda reaction are likely to develop the more disseminated and contagious, lepromatous form of leprosy.
It is noteworthy that, in areas where leprosy is not endemic, a variable but substantial proportion (62%-99%) of individuals display a positive Mitsuda reaction [3] . Indeed, a positive reaction can be induced by infection with different microbial agents, including M. tuberculosis [4] and bacille CalmetteGuérin (BCG) vaccine [5] . Therefore, a positive Mitsuda reaction is not specific to M. leprae infection but reflects a person's ability to develop an immune granuloma in response to injection of heat-killed M. leprae after diverse mycobacterial sensitizations. An understanding of the mechanisms underlying the Mitsuda reaction may thus provide new insight into the immunological control of granulomatous diseases.
Several familial studies have provided evidence for a genetic component influencing the binary outcome (i.e., positive or negative) of Mitsuda reactivity (reviewed by Ranque et al. [6] ), but none of them included genetic markers. Two genetic epidemiological studies used the quantitative value of the Mitsuda reaction as the outcome measure. The first study was a can- didate-gene study that showed evidence for linkage between Mitsuda reactivity and the SLC11A1 gene (also known as "NRAMP1") in a population from Vietnam [7] . The second study described a complex segregation analysis of the quantitative value of Mitsuda reactivity in a larger familial sample from Vietnam and reported strong evidence, independent of leprosy status, for a major gene controlling Mitsuda-reaction values. Significant residual familial correlations (between parents and children and between siblings) persisted after this major gene effect was accounted for, which strongly suggested the presence of other genetic components and/or shared environmental factors influencing Mitsuda-reaction values. Notably, this genetic effect was independent of the SLC11A1 gene [6] . To identify and locate the major genetic factors influencing the extent of the Mitsuda reaction, we performed a genomewide linkage scan in a sample of families from Vietnam.
Subjects and methods. Patients with leprosy were identified on the basis of the records of the Dermato-Venereology Hospital in Ho Chi Minh City, Vietnam, and nuclear families were ascertained through each of these index cases (i.e., probands), as detailed by Alcaïs et al. [7] . For the present study, we only retained families with at least 2 affected siblings, which ensured homogeneous exposure to M. leprae, thus minimizing the Mitsuda-reaction variability attributable to differences in the antigenic trigger. Informed consent was obtained from all participants. The study was approved by the institutional review board of the Dermato-Venereology Hospital and the local Health Authorities in Ho Chi Minh City and by the research ethics board at the Research Institute of the McGill University Health Center.
The Mitsuda test was performed both in patients with leprosy (at the time of diagnosis, prior to multidrug therapy) and in healthy individuals, by intradermal injection of 0.1 mL of lepromin (armadillo-derived; kindly provided by the National Hansen's Disease Center, Carville, LA) into the volar surface of the forearm. The reaction was measured 28-30 days later, and the diameter of induration was measured, in millimeters, by 2 independent leprologists. For further analyses, quantitative values of the Mitsuda reaction were adjusted for sex and ethnicity, because these variables had previously been shown to influence the extent of Mitsuda reactivity [6] .
Genotyping. Genotyping was performed at the Montreal Genome Center, on the ABI PRISM 3700 DNA analyzer platform. A panel of 388 highly informative microsatellite markers spanning the genome at ∼10-cM intervals was derived from a modified version of the Cooperative Human Linkage Center screening set (version 6.0). All markers were amplified as described by Mira et al. [2] . To study the SLC11A1 region on chromosomal region 2q35, we used a highly informative extended haplotype of ∼4 Mb, including 4 microsatellites (TNP1, D2S104, D2S1471, and VIL), 5 single-nucleotide polymorphisms (274C/T, 469+14G/C, 823C/T, 1465-85G/A, and D543N), and 1 tandem repeat (1992[CAAA] n ), all within the SLC11A1 gene, as detailed by Alcaïs et al. [7] . We genotyped an additional set of 12 microsatellite markers, under the same conditions, in the 2 genomic regions that we selected for fine mapping. We determined the genetic positions of the markers on the basis of the sex-averaged map available at the Marshfield Medical Research Foundation (http://www.marshfieldclinic .org). Allele binning and Mendelian-error identification were performed by use of PED-MANAGER software. The error rate for all microsatellite markers was estimated at 0.058%.
We performed model-free genomewide linkage analysis of the adjusted Mitsuda-reaction values, using the maximum-likelihood binomial (MLB) method. This approach considers the sibship as a whole (i.e., there is no need to decompose the sibship into all its constitutive sibling pairs) and does not make any assumption about the distribution of the phenotype [8] , 2 important properties in the context of our sample. The test of linkage is a maximum-likelihood ratio test that compares the likelihoods under the null hypothesis of no linkage (i.e., parental allele transmission is independent of the offspring phenotype) and the hypothesis of linkage (i.e., siblings whose phenotypes are more similar receive the same parental allele more often). The test statistic is asymptotically distributed as a 50: 50 mixture of x 2 distributions with 0 and 1 degree of freedom and can be expressed as a LOD score, which has the same distribution as does the classic model-based LOD score estimating the recombination fraction. Multipoint development of the MLB method has been implemented in an extension of the GENEHUNTER program [9] . Confidence intervals (CIs) for the location of the quantitative-trait loci (QTL) underlying the highest linkage peaks were calculated by use of the supportinterval method, in which a 1-LOD support interval corresponds to a 90% CI. We also estimated the heritability of the QTL (i.e., the proportion of phenotypic variance explained by the genetic effect) at the peaks of linkage, using the variancecomponent method as implemented in the SOLAR software (http://www.sfbr.org/solar).
Results and discussion. Nineteen nuclear families (15 of Vietnamese origin and 4 of Chinese origin), each with both parents available for genotyping, fulfilled the inclusion criteria and were selected for analysis. The number of families with 2, 3, 4, 5, 6, 7, 8, 9, 10, and 12 offspring was 1, 2, 3, 2, 5, 1, 2, 1, 1, and 1, respectively, for a total of 114 offspring. A total of 60 (53%) of the offspring were healthy; 25 (22%) had indeterminate, tuberculoid, or borderline-tuberculoid leprosy; and 29 (25%) had mid-borderline, borderline-lepromatous, or lepromatous leprosy, according to the Ridley-Jopling classification [10] . The mean age ‫ע‬ SD of the offspring when the Mitsuda reaction was analyzed was 24.3 ‫ע‬ 7.4 years (range, 6-41 years). The overall mean value ‫ע‬ SD of the Mitsuda reaction among the offspring was 5.8 ‫ע‬ 3.9 mm (range, 0.0-14.0;), with differences according to sex and ethnicity. Specifically, the mean Mitsuda-reaction values ‫ע‬ SD were 5.2 ‫ע‬ 3.7 mm for females, 6.3 ‫ע‬ 4.1 mm for males, 5.7 ‫ע‬ 3.8 mm for the Vietnamese offspring, and 6.3 ‫ע‬ 4.6 mm for the Chinese offspring. For further analyses, the Mitsuda-reaction values were adjusted for sex and ethnicity and were standardized. Figure 1 shows the distribution of the standardized residual Mitsuda-reaction values in children. Multipoint linkage analysis of the first set of microsatellites, by use of the MLB method identified 2 chromosomal regions with a multipoint LOD score 11.5 (P ! ), located at 2q35 and 17q21-25 ( figure 2A) . We sat- 
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Results are given for the 2 chromosomal regions with LOD scores 11.5 ( ) using the max-
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P ! 5 ϫ 10 imum likelihood binomial method [8] . Both first screen and fine-mapping results are shown.
a Information content, as estimated by GENEHUNTER [9] . b Markers genotyped in the first screen.
marker locus within them. The fine-mapping analysis confirmed the signals of linkage observed in these 2 regions. In chromosomal region 2q35, the highest multipoint LOD score was obtained for the markers used to define the SLC11A1 extended haplotype (LOD score, 2.11; ) (table 1) .
Ϫ4
P p 9 ϫ 10 The 90% CI for the location of the QTL was 206-219 cM on chromosome 2 ( figure 2B ). This finding was expected, because a previous candidate-gene linkage study of the quantitative Mitsuda reaction, performed with the same sample, found a suggestive linkage to SLC11A1 [7] . Nevertheless, the later genome scan provided a higher LOD score at this locus (2.11 vs 1.88), which likely was due to the adjustment for nongenetic variables influencing the Mitsuda reaction. The estimate of heritability at the SLC11A1 locus was 37%, indicating a large effect for this QTL. SLC11A1 (or NRAMP1) is the human orthologue of the murine nramp1 gene that predisposes to innate susceptibility to different intracellular pathogens, including M. lepraemurium and M. bovis (BCG) [11] . In humans, SLC11A1 is associated with pulmonary tuberculosis in different populations [1] and more strongly with rapid progression from infection to tuberculosis disease [12] . It has also been reported to be associated with other mycobacterial diseases, such as leprosy and Buruli ulcer [1] , as well as with sarcoidosis, a systemic granulomatous disease of unknown etiology [13] .
The highest multipoint LOD score was obtained for marker D17S2180, in chromosomal region 17q21 (LOD score, 2.14;
). The estimate of heritability at this locus was Ϫ4 P p 8 ϫ 10 once again very high, at 36%. The 90% CI for the location of the QTL encompassed a broad region-49-76 cM on chromosome 17 (17q21-25) (figure 1B). This chromosomal region overlaps a large cluster of immunity-related genes encoding chemokines (CCL1 -5, 7, 8, 11, 13-16, 18 , and 23), immunoregulatory transcriptional factors (STAT3, STAT5A, and STAT5B), cell-adhesion molecules (ICAM2 and Integrin b3 and a3), and inflammatory-response proteins (NOS2A). Interestingly, a genomewide scan of a Brazilian population found the same region to be linked to both leprosy and tuberculosis. Additional studies in this Brazilian population identified polymorphisms in CCL18, NOS2A, CCL4, and STAT5B to be associated with tuberculosis [14] . An association between pul-monary tuberculosis and MCP-1 (CCL2), a gene in this cluster, was also observed in both Mexican and Korean populations [15] . Finally, in a meta-analysis of 10 genome scans, Crohn disease, another granuloma-related phenotype, was found to be linked to the 17q21 chromosomal region [16] . In summary, despite the limited size of our sample, genomewide, model-free linkage analysis identified 2 regions with suggestive linkage to quantitative Mitsuda reactivity: 17q21-25 and 2q35 (SLC11A1 locus). Notably, the high estimates of heritability for these 2 loci are indicative of large QTL effects. Both regions harbor genes previously reported to be linked and/or associated with mycobacterial or other granulomatous diseases. Interestingly, when analyses were performed in the subset of 60 healthy offspring, the same linkage regions were identifiedalbeit with lower significance because of smaller sample size ( and in regions 2q35 and 17q23, respec-P p .007 P p .004 tively). These findings, coupled with the observation that, regardless of the endemicity of leprosy, the distribution of Mitsuda-reaction values is similar across countries [3] , support the view that the importance of this phenotype extends well beyond the field of leprosy. Given the high proportion of Mitsuda-reaction variability explained by the 2 regions identified here, ongoing association studies to identify the underlying genes will be of considerable importance to our understanding of in vivo granuloma formation.
